Viridian Therapeutics Ors Inc (VRDN)
EBITDA Growth
-18.57%
Quarterly · Period ending:
VRDN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-18.57%period ending
Latest reported-18.57%period ending
VRDN Quarterly EBITDA YoY % (-213.39% → -18.57%)
Year-over-year change
High-resolution chart · PNG
VRDN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -18.5669% | |
| -17.526% | |
| -44.2992% | |
| 55.0936% | |
| -55.8004% | |
| -80.3158% | |
| -19.6826% | |
| -61.0123% | |
| -17.3268% | |
| 29.5679% | |
| -44.5355% | |
| -63.6215% | |
| -87.0389% | |
| -165.6479% | |
| -57.4522% | |
| -104.66% | |
| -63.2198% | |
| -38.2588% | |
| -39.7544% | |
| -162.2193% | |
| -185.7894% | |
| -135.8902% | |
| -158.6522% | |
| 51.2186% | |
| 26.9777% | |
| 30.8107% | |
| 20.1318% | |
| -26.079% | |
| -2.3333% | |
| -158.3619% | |
| -63.7612% | |
| -53.0832% | |
| -17.5154% | |
| 35.8836% | |
| -11.2425% | |
| -220.8592% | |
| -187.7617% | |
| -149.9452% | |
| -77.6665% | |
| 42.5836% | |
| -1.5951% | |
| -6.5446% | |
| -39.4773% | |
| -92.6829% | |
| 11.8986% | |
| -1,859.542% | |
| -860.9887% | |
| -482.0557% | |
| -12,028.8886% | |
| -213.3896% |